5525-72-4 Usage
General Description
(4'-Chloro-biphenyl-4-yl)-acetic acid is a chemical compound consisting of a biphenyl group with a chloro substituent attached to the 4' position and an acetic acid group attached to the biphenyl ring. (4'-CHLORO-BIPHENYL-4-YL)-ACETIC ACID is commonly used in research and development as a building block for the synthesis of various organic compounds. It has potential applications in the pharmaceutical industry as a precursor for the synthesis of pharmaceutical drugs. Additionally, it can also be used as a starting material for the production of agrochemicals and specialty chemicals. The presence of the chloro and acetic acid groups makes this compound versatile for use in different chemical reactions and transformations. Overall, (4'-Chloro-biphenyl-4-yl)-acetic acid is an important intermediate in organic synthesis with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 5525-72-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,2 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5525-72:
(6*5)+(5*5)+(4*2)+(3*5)+(2*7)+(1*2)=94
94 % 10 = 4
So 5525-72-4 is a valid CAS Registry Number.
5525-72-4Relevant articles and documents
THIAZOLOPIPERAZINE DERIVATIVES AND COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES COMPRISING THE SAME
-
Paragraph 0118-0124; 0143; 0144, (2020/04/01)
The present invention provides a thiazolopiperazine derivative, and a pharmaceutical composition and a health functional food composition for preventing or treating autoimmune diseases containing the same as an active component. A compound represented by chemical formula 1 or a pharmaceutically acceptable salt thereof according to the present invention can have an effect of inhibiting lysophosphatidic acid 1 (LPA1) receptor activation, thereby being able to be usefully used as the pharmaceutical composition or the health functional food composition for preventing or treating LPA1-related diseases. In addition, it is possible to effectively prevent or treat not only autoimmune diseases, but also other immune-related diseases with similar mechanisms of occurrence by using the pharmaceutical composition and the health functional food composition.COPYRIGHT KIPO 2020